FDA Approves Belimumab Autoinjection for Patients 5 and Older With Active Lupus Nephritis
This approval offers pediatric patients and caregivers the first subcutaneous option that can be administered at home.
The Current, Future Roles of AI within the Pharmacy Profession
As artificial intelligence evolves from a novel technology to commonplace in health care, the pharmacy industry is adapting to its challenges and opportunities.
FDA Approves Nitisinone for Treatment of Alkaptonuria
Alkaptonuria affects approximately 1 in 250,000 to 1 million people in the United States.
The Unique Challenges, Growth in the Business of Health-System Pharmacy
From market pressures to regulatory framework, Eric Tichy, PharmD, MBA, BCPS, FCCP, FAST, discussed growth in the business of health-system pharmacy and the challenges it has faced.
FDA Approves Acoltremon Ophthalmic Solution for Dry Eye Disease
The new approval is for a first-in-class TRPM8 receptor agonist to stimulate corneal sensory nerves to increase natural tear production.
FDA Approves Hydrocortisone Oral Solution for Adrenocortical Insufficiency
The replacement therapy is indicated for patients 5 years and older, marking the first approval for an oral solution form of hydrocortisone.
